Step 2: preparation of sodium (7-oxo-3-pyrazol-1-yl-1,6-diazabicyclo[3.2.1]oct-3-en-6-yl) sulfate (Example 11)
Using the procedure described in example 9 (step 2), the intermediate 6-allyloxy-3-pyrazol-1-yl-1,6-diazabicyclo[3.2.1]oct-3-en-7-one (11a) (105 mg, 0.427 mmol) was converted into sodium (7-oxo-3-pyrazol-1-yl-1,6-diazabicyclo[3.2.1]oct-3-en-6-yl) sulfate (example 11) (69 mg,0.224 mmol, 52%) as a light yellow solid after lyophilization.